Linus Pauling Institute

Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames BN.  2002.  Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress.. Proc Natl Acad Sci U S A. 99(4):1870-5.

Myzak MC, Carr AC.  2002.  Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acid.. Redox Rep. 7(1):47-53.

Reveillaud I, Kongpachith A, Park R, Fleming JE.  1992.  Stress resistance of Drosophila transgenic for bovine CuZn superoxide dismutase.. Free Radic Res Commun. 17(1):73-85.

Fleming JE, Reveillaud I, Niedzwiecki A.  1992.  Role of oxidative stress in Drosophila aging.. Mutat Res. 275(3-6):267-79.

Hagen TM, Moreau R, Suh JH, Visioli F.  2002.  Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid.. Ann N Y Acad Sci. 959:491-507.

Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, Hagen TM.  2001.  Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid.. FASEB J. 15(3):700-6.

Kirkwood JS, Miranda CL, Bobe G, Maier CS, Stevens JF.  2016.  18O-Tracer Metabolomics Reveals Protein Turnover and CDP-Choline Cycle Activity in Differentiating 3T3-L1 Pre-Adipocytes.. PLoS One. 11(6):e0157118.

Katchamart S, Williams DE.  2001.  Indole-3-carbinol modulation of hepatic monooxygenases CYP1A1, CYP1A2 and FMO1 in guinea pig, mouse and rabbit.. Comp Biochem Physiol C Toxicol Pharmacol. 129(4):377-84.

Siddens LK, Krueger SK, Henderson MC, Williams DE.  2014.  Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.. Biochem Pharmacol. 89(1):141-7.

Williams DE, Katchamar S, Larsen-Su SA, Stresser DM, Dehal SS, Kupfer D.  2001.  Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.. Adv Exp Med Biol. 500:635-8.

Henderson MC, Krueger SK, Stevens JF, Williams DE.  2004.  Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione.. Chem Res Toxicol. 17(5):633-40.

Carr A, Frei B.  1999.  Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 13(9):1007-24.

Henderson MC, Siddens LK, Krueger SK, J Stevens F, Kedzie K, Fang WK, Heidelbaugh T, Nguyen P, Chow K, Garst M et al..  2014.  Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.. Toxicol Appl Pharmacol. 278(2):91-9.

Krueger SK, Williams DE, Yueh M-F, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.  2002.  Genetic polymorphisms of flavin-containing monooxygenase (FMO).. Drug Metab Rev. 34(3):523-32.

Siddens LK, Henderson MC, VanDyke JE, Williams DE, Krueger SK.  2008.  Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.. Biochem Pharmacol. 75(2):570-9.

Larsen-Su SA, Krueger SK, Yueh MFei, Pereira CB, Williams DE.  2002.  Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits.. Biochem Pharmacol. 63(7):1353-9.

Krueger SK, Martin SR, Yueh M-F, Pereira CB, Williams DE.  2002.  Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.. Drug Metab Dispos. 30(1):34-41.

Traber MG, Atkinson J.  2007.  Vitamin E, antioxidant and nothing more.. Free Radic Biol Med. 43(1):4-15.

Krueger SK, Henderson MC, Siddens LK, VanDyke JE, Benninghoff AD, P Karplus A, Furnes B, Schlenk D, Williams DE.  2009.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.. Drug Metab Dispos. 37(8):1785-91.